AXIM Biotechnologies AXIM Stock
AXIM Biotechnologies Price Chart
AXIM Biotechnologies AXIM Financial and Trading Overview
| AXIM Biotechnologies stock price | 0.0050 USD |
| Previous Close | 0.006 USD |
| Open | 0.0055 USD |
| Bid | 0.0051 USD x 4340000 |
| Ask | 0.0056 USD x 11140000 |
| Day's Range | 0.0055 - 0.0055 USD |
| 52 Week Range | 0.002 - 0.03 USD |
| Volume | 31.2K USD |
| Avg. Volume | 214K USD |
| Market Cap | 1.7M USD |
| Beta (5Y Monthly) | -0.238 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AXIM Valuation Measures
| Enterprise Value | 8.41M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.324215 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 90.501 |
| Enterprise Value/EBITDA | -4.463 |
Trading Information
AXIM Biotechnologies Stock Price History
| Beta (5Y Monthly) | -0.238 |
| 52-Week Change | -28.57% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.002 USD |
| 50-Day Moving Average | 0.0059 USD |
| 200-Day Moving Average | 0.00933 USD |
AXIM Share Statistics
| Avg. Volume (3 month) | 214K USD |
| Avg. Daily Volume (10-Days) | 228.01K USD |
| Shares Outstanding | 340.46M |
| Float | 243.75M |
| Short Ratio | N/A |
| % Held by Insiders | 22.39% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3257.85% |
| Gross Margin | 98.12% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 92.9K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 76.00% |
| Gross Profit (ttm) | 91.15K USD |
| EBITDA | -1883836 USD |
| Net Income Avi to Common (ttm) | -4135873 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.04K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 6.78M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.003 |
| Book Value Per Share (mrq) | -0.032 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -758995 USD |
| Levered Free Cash Flow (ttm) | -2999857 USD |
Profile of AXIM Biotechnologies
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 6191 Cornerstone Court, East |
| ZIP | 92121 |
| Phone | 858 923 4422 |
| Website | https://www.aximbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery. In addition, the company develops a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring, as well as COVID-19 rapid diagnostic tools. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
Q&A For AXIM Biotechnologies Stock
What is a current AXIM stock price?
AXIM Biotechnologies AXIM stock price today per share is 0.0050 USD.
How to purchase AXIM Biotechnologies stock?
You can buy AXIM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AXIM Biotechnologies?
The stock symbol or ticker of AXIM Biotechnologies is AXIM.
Which industry does the AXIM Biotechnologies company belong to?
The AXIM Biotechnologies industry is Biotechnology.
How many shares does AXIM Biotechnologies have in circulation?
The max supply of AXIM Biotechnologies shares is 340.46M.
What is AXIM Biotechnologies Price to Earnings Ratio (PE Ratio)?
AXIM Biotechnologies PE Ratio is now.
What was AXIM Biotechnologies earnings per share over the trailing 12 months (TTM)?
AXIM Biotechnologies EPS is 0 USD over the trailing 12 months.
Which sector does the AXIM Biotechnologies company belong to?
The AXIM Biotechnologies sector is Healthcare.